Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine for the Treatment of Opioid Use Disorder and Depression
Medical University of South Carolina
Ketamine for Older Adults Pilot
Washington University School of Medicine
Ketamine Treatment Effects on Synaptic Plasticity in Depression
New York State Psychiatric Institute
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
Mclean Hospital
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
COMPASS Pathways
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
COMPASS Pathways
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
Field Trip Health
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
Medical University of Gdansk
Chart Review of Patients Undergoing Ketamine Infusions
Brain and Cognition Discovery Foundation
Clinical Study of GH001 in Depression
GH Research Ireland Limited
LSD Therapy for Persons Suffering From Major Depression
University Hospital, Basel, Switzerland
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
MercyOne Des Moines Medical Center
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
University of Minnesota
Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery
Stanford University
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
Celon Pharma SA
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
COMPASS Pathways
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression
Celon Pharma SA
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Psych Atlanta
Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
University Health Network, Toronto
Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
The University of Texas Health Science Center, Houston
Sequential Therapy for the Treatment of Severe Bipolar Depression.
NeuroRx, Inc.
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Joshua Woolley
Intravenous Ketamine Plus Neurocognitive Training for Depression
Rebecca Price
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
Massachusetts General Hospital
Ketamine as an Adjunctive Therapy for Major Depression
St Patrick's Hospital, Ireland
Effects of Psilocybin in Major Depressive Disorder
Johns Hopkins University
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Bo Hu
Ketamine and Nitroprusside for Depression
Icahn School of Medicine at Mount Sinai
Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
VA Connecticut Healthcare System
Dance Movement Therapy in the Treatment of Depressed Patients: A Randomised Controlled Trial
University of Jyvaskyla
Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Scott A. Irwin, MD, PhD
Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
The University of Texas Health Science Center, Houston
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
University Hospital, Lille
Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Stanford University
Neurocognitive Features of Patients With Treatment-Resistant Depression
Massachusetts General Hospital
Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
VA Connecticut Healthcare System
Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
Washington University School of Medicine
Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.
St. Olavs Hospital
Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Yale University
Ketamine for Depression: An MRI Study
Massachusetts General Hospital
Ketamine Anesthesia for Improvement of Depression in ECT
VA Puget Sound Health Care System
Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
Sunnybrook Health Sciences Centre
Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
University of Alberta
Ketamine Infusion for Adolescent Depression and Anxiety
Yale University
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
The Cleveland Clinic
Heart Rate Variability in Depression
Emory University
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
University of Alabama at Birmingham
Ketamine for Depression Relapse Prevention Following ECT
St Patrick's Hospital, Ireland
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.